Nuvectis PharmavsUnitedHealth

NVCT and UNH stock compared: price, dividend, valuation and results, from SEC filings.

NVCT

Nuvectis Pharma, Inc.

$19.39

Value $667M

-4.44%
NVCT's page

UNH

UnitedHealth Group Incorporated

$339.85

Value $308B

+2.84%
UNH's page

Nuvectis Pharma (NVCT) has a market value of $667M and UnitedHealth (UNH) $308B. Over the last year, with dividends, NVCT moved +224.8% and UNH +12.9%. Dividend yield: NVCT none, UNH 2.67%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    NVCT$667M

    UNH$308B

    UNH is 463 times NVCT

  • Revenue, 12 months

    NVCT–

    UNH$450B

  • Net income, 12 months

    NVCT-$50M

    UNH$15.9B

  • Operating margin

    NVCT–

    UNH5.3%

  • ROIC

    NVCT-118.3%

    UNH11.3%

    129.6 points apart

  • P/E

    NVCT–

    UNH19.4

  • Dividend yield

    NVCT0.0%

    UNH2.7%

    2.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

NVCT+133.9%

UNH-32.4%

100200300202420252026
Returns by period
PeriodNVCTWith dividendsUNHWith dividends
1 year since November 19, 2025+224.8%Price +224.8%+12.9%Price +10.0%
3 years since November 20, 2023+133.9%+32.7% a yearPrice +133.9%-32.4%-12.2% a yearPrice -36.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

NVCTNuvectis PharmaUNHUnitedHealth

Valuation

NVCTUNH
Valuation
Price$19.39$339.85
Market value$667M$308B
Enterprise value (EV)$526M$354B
P/E–19.4
P/E, 5-year median–25.0
P/B5.33.0
EV/EBIT–14.8
Free cash flow yield–7.4%

Results and growth

NVCTUNH
Results and growth
Revenue, 12 months–$450B
Net income, 12 months-$50M$15.9B
Free cash flow, 12 months-$40M$22.8B
Earnings per share, 12 months-$1.89$17.52
Revenue growth, year on year–11.8%
Revenue growth a year, past–+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

NVCTUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin–5.3%
Net margin–3.5%
ROIC-118.3%11.3%
ROE-131.1%15.5%

Balance sheet

NVCTUNH
Balance sheet
Cash$141M$28.5B
Total debt–$74.3B
Net debt / EBITDA–1.6
Interest cover–6.2×

Dividends and buybacks

NVCTUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: NVCT or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Nuvectis Pharma or UnitedHealth?

By market value, UnitedHealth ($308B) is about 462.6 times Nuvectis Pharma ($667M), at today's prices.

How did NVCT and UNH stock do over the last 3 years?

Since November 20, 2023, NVCT's price moved +133.9% and UNH's -36.5%. With dividends: NVCT +133.9% (+32.7% a year), UNH -32.4% (-12.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, NVCT or UNH?

The dividend yield at today's price is none for Nuvectis Pharma and 2.67% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which is the better investment, Nuvectis Pharma or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.